Yogev Debbi

Yogev Debbi

Company: Mana.bio

Job title: Co-Founder & CEO


Yogev Debbi is a Co-founder and CEO of Mana.bio. Mana.bio is an AI based drug delivery startup, leveraging machine learning and AI in order to identify formulations of lipid nanoparticles drug delivery systems.
Prior to that, Yogev was a Co-founder and COO of Genome Compiler, a leading gene editing platform that was acquired by Twist Bioscience, a global leader in synthetic biology. Following the acquisition, Yogev was the General Manager of the Israel R&D center and took part of Twist IPO.
Yogev is very excited about the integration of software and machine learning with biology and is eager to leverage the integration of these two fields in order to bring disruptive products for improving health and quality of life.


Opening Remarks 8:50 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.